Skip to main content

View full-text article in PMC

. 2010 Mar 1;54(5):1973–1980. doi: 10.1128/AAC.00870-09

TABLE 3.

Resistance-associated mutations in the RT polymerase domain derived from paired PR/RT RTVs

Patient sample	RT mutation(s)
396^a^,^b	M41L, M184M/V, T215Y, K219R
471^a^,^b	M41L, D67D/N, Y181C, M184V, L210W, T215Y
440^a^,^b	M41L, M184V, L210W, T215Y
62^a	K103N, M184V, T215Y, P225P/H
477^a^,^b	M184V, T215Y
384^a^,^b	M184V
429^b	M41L, D67N, K70R, T215F, K219Q
58^b	M41L, A98A/G, K103N, Y181Y/C, G190G/A, L210W, T215Y
138^b	M41M/L, D67D/N, T215Y
87^b	M41L, L210W
474^b	M41L, D67N, K101E, Y181C, M184V, G190A, L210W, T215Y, K219N
249^b	M41L, D67N, M184V, G190G/A, T215H/Y, K219N
439^b	M41L, D67N, M184V, L210W, T215Y
442^b	M41L, D67N, T69D, L100I, K103N, M184V, L210W, T215Y, K219N

^a

Patients with reduced susceptibility to DLV, EFV or NVP.

^b

Patients with reduced susceptibility to ZDV.